Modulating alloimmune responses with plasmapheresis and IVIG

Current Drug Targets - Cardiovascular and Haematological Disorders

Volumn 5, Issue 3, 2005, Pages 215-222

  Warren, Daniel S ^a,b   Simpkins, Christopher E ^a   Cooper, Matthew ^a   Montgomery, Robert A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

ABO incompatible; Desensitization; Intravenous immunoglobulin; Plasmapheresis; Positive crossmatch; Renal transplantation

Indexed keywords

15 DEOXYSPERGUALIN; ALBUMIN; AZATHIOPRINE; CD20 ANTIBODY; CORTICOSTEROID DERIVATIVE; CYTOKINE ANTIBODY; DACLIZUMAB; FRESH FROZEN PLASMA; HLA ANTIBODY; IMMUNOGLOBULIN; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

ANTIBODY PRODUCTION; BLOOD DONOR; BLOOD GROUP ABO INCOMPATIBILITY; CLINICAL PROTOCOL; CYTOKINE PRODUCTION; CYTOTOXICITY; DESENSITIZATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; FATALITY; GRAFT FAILURE; GRAFT SURVIVAL; HLA MATCHING; HUMAN; IMMUNOADSORPTION; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; IRRADIATION; KIDNEY DYSFUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; LOW DRUG DOSE; METHODOLOGY; PLASMAPHERESIS; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; REVIEW; RISK; RISK REDUCTION; SINGLE DRUG DOSE; SPLENECTOMY; SUBSTITUTION THERAPY; SURVIVAL RATE; THROMBOSIS; TREATMENT OUTCOME; VASCULAR DISEASE; XENOTRANSPLANTATION;

ABO BLOOD-GROUP SYSTEM; BLOOD GROUP INCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; KIDNEY TRANSPLANTATION; PLASMAPHERESIS;

EID: 21044446161     PISSN: 15680061     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568006054064735     Document Type: Review

References (43)

1. Patel, R., Terasaki, P. I. Significance of the positive crossmatch test in kidney transplantation. N. Engl. J. Med., 1969, 280, 735-739.
2. Williams, G. M., Hume, D. M., Hudson, R. P. Jr., Morris, P. J., Kano, K., Milgrom, F. "Hyperacute" renal-homograft rejection in man. N. Engl. J. Med., 1968, 279, 611-618.
3. Kissmeyer-Nielsen, F., Olsen, S., Petersen, V. P., Fjeldborg, O. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet, 1966, 2, 662-665.
4. URREA, UNOS: 2002 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1992-2001 Rockville (MD): HHS/HRSA/OSP/DOT, 2003.
5. Hume, D. M., Merill, J. P., Miller, B. F., Thorn, D. W. Experiences with renal allotransplantation in the human: report of nine cases. J. Clin. Invest., 1955, 34, 327-332.
6. Starzl, T. E., Machioro, T. L., Holmes, J. H., Hermann, G., Brittain, R. S., Stonington, O. H., Talmage, D. W., Wadell, W. R. Renal homografts in patients with major dono-recipient blood group incompatibilities. Surgery, 1964, 55, 195-200.
7. Glotz, D., Antoine, C., Julia, P., Pegaz-Fiornet, B., Duboust, A., Boudjeltia, S., Fraoui, R., Combes, M., Bariety, J. Intravenous immunoglobulins and transplantation for patients with anti-HLA antibodies. Transpl. Int., 2004, 17, 1-8.
8. Glotz, D., Antoine, C., Julia, P., Suberbielle-Boissel, C., Boudjeltia, S., Fraoui, R., Hacen, C., Duboust, A., Bariety, J. Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg). Am. J. Transplant., 2002, 2, 758-760.
9. Glotz, D., Haymann, J. P., Sansonetti, N., Francois, A., Menoyo-Calonge, V., Bariety, J., Druet, P. Suppression of HLA-specific alloantibodies by high-dose intravenous immunoglobulins (IVIg). A potential tool for transplantation of immunized patients. Transplantation, 1993, 56, 335-337.
10. Jordan, S. C., Vo, A. A., Nast, C. C., Tyan, D. Use of high-dose human intravenous immunoglobulin therapy in sensitized patients awaiting transplantation: the Cedars-Sinai experience. Clin. Transpl., 2003, 193-198.
11. Jordan, S. C., Vo, A., Bunnapradist, S., Toyoda, M., Peng, A., Puliyanda, D., Kamil, E., Tyan, D. Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients. Transplantation, 2003, 76, 631-636.
12. Tyan, D. B., Li, V. A., Czer, L., Trento, A., Jordan, S. C. Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ. Transplantation, 1994, 57, 553-562.
13. Montgomery, R. A., Zachary, A. A., Racusen, L. C., Leffeil, M. S., King, K. E., Burdick, J., Maley, W. R., Ratner, L. E. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation, 2000, 70, 887-895.
14. Montgomery, R. A., Cooper, M., Kraus, E., Rabb, H., Samaniego, M., Simpkins, C. E., Sonnenday, C. J., Ugarte, R. M., Warren, D. S., Zachary, A. A. Renal transplantation at the Johns Hopkins Comprehensive Transplant Center. Clin. Transpl., 2003, 199-213.
15. Gloor, J. M., DeGoey, S. R., Pineda, A. A., Moore, S. B., Prieto, M., Nyberg, S. L., Larson, T. S., Griffin, M. D., Textor, S. C., Velosa, J. A., Schwab, T. R., Fix, L. A., Stegall, M. D. Overcoming a positive crossmatch in living-donor kidney transplantation. Am. J. Transplant., 2003, 3, 1017-1023.
16. Gloor, J. M., Lager, D. J., Moore, S. B., Pineda, A. A., Fidler, M. E., Larson, T. S., Grande, J. P., Schwab, T. R., Griffin, M. D., Prieto, M., Nyberg, S. L., Velosa, J. A., Textor, S. C., Platt, J. L., Stegall, M. D. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation, 2003, 75, 971-977.
17. Schweitzer, E. J., Wilson, J. S., Fernandez-Vina, M., Fox, M., Gutierrez, M., Wiland, A., Hunter, J., Farney, A., Philosophe, B., Colonna, J., Jarrell, B. E., Bartlett, S. T. A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants. Transplantation, 2000, 70, 1531-1536.
18. Kazatchkine, M. D., Kaveri, S. V. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N. Engl. J. Med., 2001, 345, 747-755.
19. Rault, R., Piraino, B., Johnston, J. R., Oral, A. Pulmonary and renal toxicity of intravenous immunoglobulin. Clin. Nephrol., 1991, 36, 83-86.
20. Winward, D. B., Brophy, M. T. Acute renal failure after administration of intravenous immunoglobulin: review of the literature and case report. Pharmacotherapy, 1995, 15, 765-772.
21. Gupta, N., Ahmed, I., Nissel-Horowitz, S., Patel, D., Mehrotra, B. Intravenous gammglobulin-associated acute renal failure. Am. J. Hematol., 2001, 66, 151-152.
22. Cantu, T. G., Hoehn-Saric, E. W., Burgess, K. M., Racusen, L., Scheel, P. J. Acute renal failure associated with immunoglobulin therapy. Am. J. Kidney Dis., 1995, 25, 228-234.
23. http://www.fda.gov/medwatch/SAFETY/2002/baxter_igiv.htm: Accessed November 12, 2004. Edited by.
24. Ahsan, N., Wiegand, L. A., Abendroth, C. S., Manning, E. C. Acute renal failure following immunoglobulin therapy. Am. J. Nephrol., 1996, 16, 532-536.
25. Sonnenday, C. J., Ratner, L. E., Zachary, A. A., Burdick, J. F., Samaniego, M. D., Kraus, E., Warren, D. S., Montgomery, R. A. Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match. Transplant. Proc., 2002, 34, 1614-1616.
26. Karpinski, M., Rush, D., Jeffery, J., Exner, M., Regele, H., Dancea, S., Pochinco, D., Birk, P., Nickerson, P. Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch. J. Am. Soc. Nephrol., 2001, 12, 2807-2814.
27. Zachary, A. A., Montgomery, R. A., Ratner, L. E., Samaniego-Picota, M., Haas, M., Kopchaliiska, D., Leffell, M. S. Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients. Transplantation, 2003, 76, 1519-1525.
28. Gloor, J. M., DeGoey, S., Ploeger, N., Gebel, H., Bray, R., Moore, S. B., Dean, P. G., Stegall, M. D. Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation. Transplantation, 2004, 78, 221-227.
29. Sonnenday, C. J., Warren, D. S., Cooper, M., Samaniego, M., Haas, M., King, K. E., Shirey, R. S., Simpkins, C. E., Montgomery, R. A. Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am. J. Transplant., 2004, 4, 1315-1322.
30. Stegall, M. D., Larson, T. S., Prieto, M., Gloor, J., Textor, S., Nyberg, S., Sterioff, S., Ishitani, M., Griffin, M., Schwab, T., Talor, S., Cosio, F., Kudva, Y., Dicke-Henslin, D., Kreps, M., Fix, L., Bauer, C., Murphy, M., Kosberg, K., Tarara, D., Velosa, J. Living-donor kidney transplantation at Mayo Clinic--Rochester. Clin. Transpl., 2002, 155-161.
31. Alexandre, G. P., Squifflet, J. P., De Bruyere, M., Latinne, D., Reding, R., Gianello, P., Carlier, M., Pirson, Y. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant. Proc., 1987, 19, 4538-4542.
32. Alexandre, G. P., Squifflet, J. P., De Bruyere, M., Latinne, D., Moriau, M., Ikabu, N., Carlier, M., Pirson, Y. Splenectomy as a Prerequisite for Successful Human ABO-Incompatible Renal Transplantation. Transplant. Proc., 1985, 17, 138-143.
33. Tanabe, K., Takahashi, K., Sonda, K., Tokumoto, T., Ishikawa, N., Kawai, T., Fuchinoue, S., Oshima, T., Yagisawa, T., Nakazawa, H., Goya, N., Koga, S., Kawaguchi, H., Ito, K., Toma, H., Agishi, T., Ota, K. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience. Transplantation, 1998, 65, 224-228.
34. Breimer, M. E., Samuelsson, B. E. The specific distribution of glycolipid-based blood group A antigens in human kidney related to A1/A2, Lewis, and secretor status of single individuals. A possible molecular explanation for the successful transplantation of A2 kidneys into O recipients. Transplantation, 1986, 42, 88-91.
35. Clausen, H., Levery, S. B., Nudelman, E., Tsuchiya, S., Hakomori, S. Repetitive A epitope (type 3 chain A) defined by blood group A1-specific monoclonal antibody TH-1: chemical basis of qualitative A1 and A2 distinction. Proc. Natl. Acad. Sci. USA, 1985, 82, 1199-1203.
36. Economidou, J., Hughes-Jones, N. C., Gardner, B. Quantitative measurements concerning A and B antigen sites. Vox Sang, 1967, 12, 321-328.
37. Nelson, P. W., Helling, T. S., Pierce, G. E., Ross, G., Shield, C. F., Beck, M. L., Blake, B., Cross, D. E. Successful transplantation of blood group A2 kidneys into non-A recipients. Transplantation, 1988, 45, 316-319.
38. Alkhunaizi, A. M., de Mattos, A. M., Barry, J. M., Bennett, W. M., Norman, D. J. Renal transplantation across the ABO barrier using A2 kidneys. Transplantation, 1999, 67, 1319-1324.
39. Sorensen, J. B., Grant, W. J., Belnap, L. P., Stinson, J., Fuller, T. C. Transplantation of ABO group A2 kidneys from living donors into group O and B recipients. Am. J. Transplant., 2001, 1, 296-299.
40. Tyden, G., Kumlien, G., Fehrman, I. Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Transplantation, 2003, 76, 730-731.
41. Takahashi, K., Saito, K., Takahara, S., Okuyama, A., Tanabe, K., Toma, H., Uchida, K., Hasegawa, A., Yoshimura, N., Kamiryo, Y. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am. J. Transplant., 2004, 4, 1089-1096.
42. Platt, J. L., Fischel, R. J., Matas, A. J., Reif, S. A., Bolman, R. M., Bach, F. H. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation, 1991, 52, 214-220.
43. Warren, D. S., Zachary, A. A., Sormenday, C. J., King, K. E., Cooper, M., Ratner, L. E., Shirey, R. S., Haas, M., Leffell, M. S., Montgomery, R. A. Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers. Am. J. Transplant., 2004, 4, 561-568.